1.                        Alonzeau, J., Alexandre, D., Jeandel, L., Courel, M., Hautot, C., El Yamani, F.Z., Gobet, F., Leprince, J., Magoul, R., Amarti, A., Pfister, C., Yon, L., Anouar, A. and Chartrel, N.: The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells. Eur. J. Cancer 49:511-519 (2013). http://www.sciencedirect.com/science/article/pii/S0959804912005503

2.                        Berthon, A., Drelon, C., Ragazzon, B., Broulkroun, S., Tissier, F., Amar, L., Samson-Couterie, B., Zennaro, M.C., Plouin, P.F., Skah, S., Plateroti, M., Lefebvre, H., Sahut-Barnola, I., Batisse-Lignier, M., Assié, G., Lefrançois-Martinez, A.M., Bertherat, J., Martinez, A., and Val, P.: WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Hum. Mol. Genet. (in press).

3.                        Bons J, Moreau L, Lefebvre H. Adrenal disorders in human immunodeficiency virus (HIV) infected patients.Ann Endocrinol (Paris). 2013 (in press).

4.                        Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L; GTE Group. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 98:E403-8 (2013).

5.                        Carré A, Hamza RT, Kariyawasam D, Guillot L, Teissier R, Tron E, Castanet M, Dupuy C, El Kholy M, Polak M. First FOXE1 Mutation in Bamforth Syndrome Causing Thyroid-Gene Overactivation. Thyroid. 2013 (in press)

6.                        Castanet M, Mallet E, Kottler ML. Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations. J Pediatr. 163:1208-10 (2013).

7.                        El Yamani, F.Z., Yon, L., Guérin, M., El Ouezzani, S., Alaoui, A., Chartrel, N., Anouar, Y. and Magoul, R.: Immunocytochemical expression of EM66 within the hypothalamic parvocellular paraventricular nucleus: colocalization with CRH and TRH but no plasticity related to acute stress and thyroidectomy in the rat. Regulatory Peptides 182:28-34 (2013)

8.                        Lefebvre, H., Prévost, G. and Louiset, E.: Autocrine/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticisms. Eur. J. Endocrinol. 169:R115-R138 (2013). http://eje-online.org/content/169/5/R115.long

9.                        Louiset, E., Duparc, C., Young, J., Renouf, S., Tetsi Nomigni, M., Boutelet, I., Libé, R., Bram, Z., Groussin, L., Caron, P., Tabarin, A., Grunenberger, F., Christin-Maitre, S., Bertagna, X., Kuhn, J.M., Anouar, Y., Bertherat, J. and Lefebvre, H.: Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N. Engl. J. Med. 369, 22: 2115-2125 (2013).



10.                    Prévost, G., Arabo, A., Jian, L., Quelennec, E., Cartier, D., Hassan, S., Falluel-Morel, A., Tanguy, Y., Gargani, S., Lihrmann, I., Kerr-Conte, J., Lefebvre, H., Pattou, F. and Anouar, Y.: The PACAP-regulated gene selenoprotein T is abundantly expressed in mouse and human β cells and its targeted inactivation impaires glucose tolerance. Endocrinology 154:3796-3806 (2013).

11.                    Prévost G, Ducrotté P, Cailleux A, Khalfi K, Basuyau JP, Lefebvre H, Kuhn JM. Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study. Neurogastroenterol Motil. 25(8):694-9 (2013).

12.                    Rives N, Milazzo JP, Perdrix A, Castanet M, Joly-Hélas G, Sibert L, Bironneau A, Way A, Macé B. The feasibility of fertility preservation in adolescents with Klinefelter syndrome. Hum Reprod. 28:1468-79 (2013).

13.                    Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, Giraud S, Niccoli P, Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Parfait B, Chabre O, Castermans E, Beckers A, Ruszniewski P, Le Bras M, Delemer B, Bouchard P, Guilhem I, Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G, Lecomte P, Penfornis A, Bihan H, Archambeaud F, Kerlan V, Duron F, Kuhn JM, Vergès B, Rodier M, Renard M, Sadoul JL, Binquet C, Goudet P. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study. Hum Mol Genet. 22:1940-8 (2013).

14.                    Zoghlami A, Roussel F, Sabourin JC, Kuhn JM, Marie JP, Dehesdin D, Choussy O. BRAF mutation in papillary thyroid carcinoma: Predictive value for long-term prognosis and radioiodine sensitivity. Eur Ann Otorhinolaryngol Head Neck Dis. 2013 (in press)



15.                    Boulkroun, S., Beuschlein, F., Rossi, G.P., Golib-Dzib, J.F., Fischer, E., Amar, L., Mulatero, P., Samson-Couterie, B., Hahner, S., Quinkler, M., Fallo, F., Letizia, C., Allolio, B., Ceolotto, G., Cicala, M.V., Lang, K., Lefebvre, H., Lenzini, L., Maniero, C., Monticone, S., Perrocheau, M., Pilon, C., Plouin, P.F., Rayes, N., Seccia, T.M., Veglio, F., Williams, T.A., Zinnamosca, L., Mantero, F., Benecke, A., Jeunemaitre, X., Reincke, M. and Zennaro, M.C.: Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59:592-598 (2012).

16.                    Castanet, M. and Wieliczko, M.C.: Endocrine complications of cystic fibrosis in childhood. Arch. Pediatr. 19:S27-S29(2012).

17.                    Galusca, B., Jeandel, L., Germain, N., Alexandre, D., Leprince, J., Anouar, Y., Estour, B. and Chartrel, N.: Orexigenic neuropeptide 26RFa: new evidence for an adaptive profile of appetite regulation in anorexia nervosa. J. Clin. Endocrinol. Metab. 97:2012-2018 (2012)

18.                    Gatta-Cherifi, B., Chabre, O., Murat, A., Niccoli, P., Cardot-Bauters, C., Rohmer, V., Young, J., Delemer, B., Du Boullay, H., Verger, M.F., Kuhn, J.M., Sadoul, J.L., Ruszniewski, P., Beckers, A., Monsaingeon, M., Baudin, E., Goudet, P. and Tabarin, A.: Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. Eur. J. Endocrinol. 166:269-279 (2012).

19.                    Guillemot, J., Thouennon, E., Guerin, M., Vallet-Erdtmann, V., Ravni, A., Montero-Hadjadje, M., Lefebvre,  H., Klein, M., Muresan, M., Seidah, N.G., Anouar, Y. and Yon, L.: Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66. J. Mol. Endocrinol. 48:115-127 (2012)

20.                    Lefebvre, H.: Corticotroph deficiency. Ann. Endocrinol. (Paris). 73:135-137 (2012).

21.                    Libé, R., Fratticci, A., Lahlou, N., Jornayvaz, F.R., Tissier, F., Louiset, E., Guibourdenche, J., Vieillefond, A., Zerbib, M. and Bertherat, J.: A Rare Cause of Hypertestosteronemia in a 68-Year-Old Patient: A Leydig Cell Tumor Due to a Somatic GNAS (Guanine Nucleotide-Binding Protein, Alpha-Stimulating Activity Popylpetide 1)-Activating Mutation. J. Androl. 33:578-84 (2012)

22.                    Piton, N., Gobet, F., Werquin, C., Landréat, A., Lefebvre, H., Pfister, C., Sabourin, JC.: Retroperitoneal bronchogenic cyst. Ann. Pathol. 32:267-270 (2012).

23.                    Prévost, G., Eas, F., Duparc, C., Cauliez, B., Laquérrière, A., Fréger, P., Lefebvre, H. and Kuhn, J.M.: Study of the involvement of pancreastatin in the physiopathology of diabetes mellitus associated with nonsecreting pituitary adenomas. Horm. Metab. Res. 44:861-865 (2012)

24.                    Teissier, R., Guillot, L., Carré, A., Morandini, M., Stuckens, C., Ythier, H., Munnich, A., Szinnai, G., de Blic, J., Clement, A., Leger, J., Castanet, M., Epaud, R. and Polak, M.: Multiplex Ligation-dependent Probe Amplification improves the detection rate of NKX2.1 mutations in patients affected by brain-lung-thyroid syndrome. Horm. Res. Paediatr. 77:146-151 (2012).



25.                    Alexandre, D., Alonzeau, J., Bill, B.R., Ekker, S.C., and Waschek, J.A.: Expression Analysis of PAC1-R and PACAP Genes in Zebrafish Embryos. J. Mol. Neurosci. 43:94-100 (2011).

26.                    Boulkroun, S., Samson-Couterie, B., Golib-Dzib, J.F., Amar, L., Plouin, P.F., Sibony, M., Lefebvre, H., Louiset, E., Jeunemaitre, X., Meatchi, T., Benecke, A., Lalli, E. and Zennaro, M.C.:
Aldosterone producing adenoma formation in the adrenal cortex involves expression of
stem/progenitor cell markers. Endocrinology 152:4753-4763 (2011)

27.                    Briassoulis, G., Damjanovic, S., Xekouki, P., Lefebvre, H. and Stratakis, C.A.: The glucocorticoid
receptor and its expression in anterior pituitary and the adrenal cortex: a source of
variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and
adrenal tumors. Endocr. Pract. 8:1-27 (2011)

28.                    Carre, A., Rachdi, L., Tron, E., Richard, B., Castanet, M., Schlumberger, M., Bidart, J.M., Szinnai, G. and Polak, M.: Hes1 Is Required for Appropriate Morphogenesis and Differentiation during Mouse Thyroid Gland Development. PLoS One 6:e16752 (2011)

29.                    Chafai, M., Basille, M., Galas, L., Rostène, W., Gressens, P., Vaudry, H., Gonzalez, B.J. and Louiset, E.: Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide promote the genesis of calcium currents in differentiating mouse embryonic stem cells. Neuroscience 199:103-115 (2011).

30.                    Chartrel, N., Alonzeau, J., Alexandre, D., Jeandel, L., Alvear-Perez, R., Leprince, J., Boutin, J., Vaudry, H., Anouar, Y. and Llorens-Cortes, C.: The RFamide neuropeptide 26RFa and its role in the control of neuroendocrine functions. Front. Neuroendocrinol . 32:387-397 (2011) http://www.sciencedirect.com/science/article/pii/S0091302211000501

31.                    Réaux-Le Goazigo, Bodineau, L., Picco, N., Jeandel, L., Chartrel, N., Knauf, C., Raad, C., Valet, P. and Llorens-Cortes, C.: Apelin and the proopiomelanocortin system: A new regulatory pathway of hypothalamic α-MSH release. Am. J. Physiol. 301:E955-966 (2011)



32.                    Agirregoitia, N., Bizet, P., Agirregoitia, E., Boutelet, I., Peralta, L., Vaudry, H. and Jégou, S.: Prolyl endopeptidase mRNA expression in the central nervous system during rat development. J
Chem Neuroanat.
40:53-62 (2010).)

33.                    Assie, G., Louiset, E., Sturm, N., Rénée-Corail, F., Groussin, L., Bertherat, J., Thomas, M., Lefebvre, H., Feige, J.J., Clauser, E., Chabre, O. and Cherradi, N.: Systematic analysis of G-protein coupled receptor genes expression in ACTH-independent Macronodular Adrenocortical Hyperplasia identifies novel targets for pharmacological control of adrenal Cushing’s syndrome. J. Clin. Endocrinol. Metab. 95:E253-E262 (2010).http://jcem.endojournals.org/content/95/10/E253.long

34.                    Bellien, J., Costentin, A., Dutheil-Maillochaud, B., Iacob, M., Kuhn, J.M., Thuillez, C. and Joannides, R.: Early stage detection of conduit artery endothelial dysfunction in patients with type 1 diabetes. Diab. Vasc.Dis. Res. 7:158-66 (2010).

35.                    Berthon, A., Sahut-Barnola, I., Lambert-Langlais, S., de Joussineau, C., Damon-Soubeyrand, C., Louiset, E., Taketo, M.M., Tissier, F., Bertherat, J., Lefrançois-Martinez, A.M., Martinez, A. and Val, P.: Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum. Mol. Genet. 19:1561-1576 (2010).

36.                    Boulkroun, S., Samson-Couterie, B., Golib Dzib, J.F., Lefebvre, H., Louiset, E., Amar, L., Plouin, P.F., Lalli, E., Jeunemaitre, X., Benecke, A., Meatchi, T. and Zennaro, M.C.: Adrenal cortex remodeling and functional glomeruloza hyperplasia in primary aldosteronism. Hypertension 56:885-892 (2010).

37.                    Chanson, P., Cailleux-Bounacer, A., Kuhn, J.M., Weryha, G., Chabre, O., Borson-Chazot,
F., Dubois, S., Vincent-Dejean, C., Brue, T., Fedou, C., Bresson, J.L., Demolis, P. and
Souberbielle, J.C
.: Comparative validation of the growth hormone-releasing hormone and
arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone
assay conforming to recent international recommendations. J. Clin. Endocrinol. Metab.
95:3684-3692 (2010).

38.                    El Yamani FZ, Yon L, Guérin M, El Ouezzani S, Alaoui A, Chartrel N, Anouar Y, Magoul R. EM66-containing neurones in the hypothalamic parvicellular paraventricular nucleus of the rat: no plasticity related to acute immune stress. Neuro Endocrinol Lett. 2010 31:609-15

39.                    Libé, R., Coste, J., Guignat, L., Tissier, F., Lefebvre, H., Barrande, G., Ajzenberg, C., Tauveron, I., Clauser, E., Dousset, B., Bertagna, X., Bertherat, J. and Groussin, L.: Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study
of 32 patients with overt or subclinical Cushing's syndrome. Eur. J. Endocrinol. 
163:129-138 (2010).

40.                    Louiset, E., Gobet, F., Libé, R., Horvath, A., Renouf, S., Cariou, J., Rothenbuhler, A., Bertherat, J., Clauser, E., Grise, P., Stratakis, C.A., Kuhn, J.M. and Lefebvre, H.: ACTH-Independent Cushing's Syndrome with Bilateral Micronodular Adrenal Hyperplasia and Ectopic Adrenocortical Adenoma. J. Clin. Endocrinol. Metab. 95:18-24 (2010). http://jcem.endojournals.org/content/95/1/18.long

41.                    Moreau, L., Gobet, F., Grise, F., Perraudin, V., and Lefebvre, H. : Marginal-Zone Lymphoma Mimicking Adrenal Myelolipoma at Computed Tomography Scan. J. Clin. Endocrinol. Metab. 95:4173-4174 (2010).

42.                    Polito, A., Lorin de la Grandmaison, G., Mansart, A., Louiset, E., Lefebvre, H., Sharshar, T. and Annane, D.: Human and experimental septic shock are characterized by depletion of lipid
droplets in the adrenals. Intensive Care Med. 36:1852-1858 (2010).

43.                    Proust-Lemoine, E., Saugier-Véber, P., Lefranc, D., Dubucquoi, S., Ryndak, A., Buob, D., Lalau, J.D., Desailloud, R., Weill, J., Prin, L., Lefebvre, H. and Wémeau, J.L.: Autoimmune Polyendocrine Syndrome Type 1 in North-Western France: AIRE Gene Mutation Specificities and Severe Forms Needing Immunosuppressive Therapies. Horm. Res. Paediatr. 74:275-284 (2010).

44.                    Proust-Lemoine, E., Saugier-Veber, P., Lefebvre, H., Lefranc, D., Prin, L., Weill, J., Carel, J.C. and Wemeau, J.L.: Autoimmune polyendocrine syndrome type 1. Arch Pediatr. 17:597-598 (2010).

45.                    Thouënnon, E., Pierre, A., Tanguy, Y., Guillemot, J., Manecka, D.L., Guérin, M., Ouafik, L., Muresan, M., Klein, M., Bertherat, J., Lefebvre, H., Plouin, P.F., Yon, L. and Anouar, Y.: Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival. Endocr. Relat. Cancer 17:637-651 (2010).



46.                    Cailleux-Bounacer, A., Rohmer, V., Lahlou, N., Lefebvre, H., Roger, M. and Kuhn, J.M.: Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men. Int. J. Androl. 32:57-65 (2009).

47.                    Castinetti, F., Nagai, M., Morange, I., Dufour, H., Caron, P., Chanson, P., Cortet-Rudelli, C., Kuhn, J.M., Conte-Devolx, B., Regis, J. and Brue, T.: Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J. Clin. Endocrinol. Metab. 94:3400-3407 (2009).

48.                    Cohade, C., Broussaud, S., Louiset, E., Bennet, A., Huyghe, E. and Caron, P.: Ectopic cushing’s syndrome due to a pheochromocytoma: a new case in the post-partum and review of literature. Gynecol. Endocrinol. 25:624-627 (2009).

49.                    Guillemot, J., Compagnon, P., Cartier, D., Thouennon, E., Bastard, C., Lihrmann, I., Pichon, P., Thuillez, C., Plouin, P.F., Bertherat, J., Anouar, Y., Kuhn, J.M., Yon, L. and Lefebvre, H. : Metoclopramide stimulates catecholamine and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors. Endocr. Relat. Cancer 16:281-290 (2009). http://erc.endocrinology-journals.org/content/16/1/281.long

50.                    Lambert-Langlais, S., Pointud, J.C., Lefrançois-Martinez, A.M., Volat, F., Manin, M., Coudoré, F., Val, P., Sahut-Barnola, I., Ragazzon, B., Louiset, E., Delarue, C., Lefebvre, H., Urade, Y., Martinez, A.: Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions. PLoS One. e7309 (2009).

51.                    Lectez, B., Jeandel, L., El-Yamani, F.Z., Arthaud, S., Alexandre, D., Mardargent, A., Jégou, S., Mounien, L., Bizet, P., Magoul, R., Anouar, Y. and Chartrel, N.: The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus. Endocrinology 150:2342-2350 (2009). http://endo.endojournals.org/content/150/5/2342.long

52.                    Louiset, E., Stratakis, C.A., Perraudin, V., Griffin, K.J., Libé, R., Cabrol, S., Fève, B., Young, J., Groussin, L., Bertherat, J. and Lefebvre, H.: The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. J. Clin. Endocrinol. Metab. 94:2406-2413 (2009). http://jcem.endojournals.org/content/94/7/2406.long

53.                    Mounien, L., Do-Régo, J.C., Bizet, P., Boutelet, I., Gourcerol, G., Fournier, A., Brabet, P., Costentin, J., Vaudry, H. and Jégou, S.: Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology 34:424-435 (2009).

54.                    Rod, A., Voicu, M., Chiche, L., Bazille, C., Mittre, H., Louiset, E., Reznik, Y.: Cushing's syndrome associated with a nested stromal epithelial tumor of the liver: hormonal, immunohistochemical, and molecular studies. Eur. J. Endocrinol. 161:805-810 (2009).



55.                    Azizi, M., Iturrioz, X., Blanchard, A., Peyrard, S., De Mota, N., Chartrel, N., Marelle, L., Vaudry, H., Corvol, P. and Llorens-Cortes, C.: Osmotic stimulation induces opposite regulation of plasma apelin and vasopressin levels in humans. J. Am. Soc. Nephrol. 19:1015-1024 (2008).

56.                    Cailleux-Bounacer, A., Reznik, Y., Cauliez, B., Menard, J.F., Duparc, C. and Kuhn, J.M. : Evaluation of endocrine testing of Leydig cell function using extractive and recombinant human chorionic gonadotropin and different doses of recombinant human LH in normal men. Eur. J. Endocrinol. 159:171-178 (2008).

57.                    Chanson, P., Borson-Chazot, F., Kuhn, J.M., Blumberg, J., Maisonobe, P. and Delemer, B.: Lanreotide Acromegaly Study Group. Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly. Clin. Endocrinol. (Oxf). 69:299-305 (2008).

58.                    Colao, A., Marek, J., Goth, M.I., Caron, P., Kuhn, J.M., Minuto, F.M. and Weissman, N.J.:
No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly. J. Clin. Endocrinol. Metab. 93:2243-2248 (2008).

59.                    Dubessy, C., Cartier, D., Lectez, B., Bucharles, C., Chartrel, N., Montero-Hadjadje, M., Bizet, P., Chatenet, D., Tostivint, H., Scalbert, E., Leprince, J., Vaudry, H., Jégou, S. and Lihrmann, I.: Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction. J. Neurochem. 107:361-374 (2008).

60.                    Folope, V., Hellot, M.F., Kuhn, J.M., Ténière, P., Scotté, M. and Déchelotte, P.: Weight loss and quality of life after bariatric surgery: a study of 200 patients after vertical gastroplasty or adjustable gastric banding. Eur. J. Clin. Nutr. 62:1022-1030 (2008).

61.                    Joubert, M., Louiset, E., Do-Rego, J.L., Contesse, V., Kong, L.C., Benhaim, A., Mittre, H., Lefebvre, H., Reznik, Y.: Aberrant adrenal sensitivity of vasopressin in adrenal tumors associated with subclinical or overt autonomous hypercortisolism: is it explained by an overexpresssion of vasopressin receptors? Clin. Endocrinol. (2008) 68:692-699.

62.                    Louiset, E., Contesse, V., Groussin, L., Cartier, D., Duparc, C., Perraudin, V., Bertherat, J. and Lefebvre, H.: Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing’s syndrome: molecular, immunohistochemical and pharmacological correlates. J. Endocrinol. (2008) 196:1-9.

63.                    Louiset, E., Isvi, K., Gasc, J.M., Duparc, C., Cauliez, B., Laquerrière, A., Kuhn, J.M. and Lefebvre, H.: Ectopic expression of serotonin7 (5-HT7) receptors in an adrenocortical carcinoma cosecreting renin and cortisol. Endocr. Relat. Cancer 15:1025-1034 (2008) http://erc.endocrinology-journals.org/content/15/4/1025.long

64.                    Vuillermet, P., Cauliez, B., Fréger, P., Vannier, J.P., Pellerin, A. and Kuhn, J.M.: Simultaneous suprasellar and pineal germ cell tumors in five late stage adolescents: clinical, endocrinological studies and prolonged follow-up. J. Pediatr. Endocrinol. Metab. 21:1169-1178 (2008).



65.                    Bachelot, A., Laborde, K., Bresson, J..L, Plu-Bureau, G., Raynaud, A., Bertagna, X., Mogenet, A., Mansour, M., Lucas-Jouy, V., Gayno, J.P., Reznik, Y., Kuhn, J.M., Billaud, L., Vacher-Lavenu, M.C., Putterman, M., Mowszowicz, I., Touraine, P., Kuttenn, F.: Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism. J Endocrinol Invest. 30:636-46 (2007).)

66.                    Bruzzone, F., Lectez, B., Alexandre, D., Jégou, S., Mounien, L., Tollemer, H., Chatenet, D., Leprince, J., Vallarino, M., Vaudry, H. and Chartrel, N.: Distribution of 26RFa binding sites and GRP103 mRNA in the central nervous system of the rat. J. Comp. Neurol. 503:573-591 (2007)  http://onlinelibrary.wiley.com/doi/10.1002/cne.21400/abstract;jsessionid=C4DEE6D863B35402157A04FB345A5304.f02t03

67.                    Castinetti, F., Nagai, H., Dufour, H., Kuhn, J.M., Morange, P., Jaquet, P., Conte-Devolx, B., Regis, J., Brue, T.: Gamma knife radiosurgery is a sucessfull adjunctive treatment in Cushing's disease. Eur. J. Endocrinol. 156:91-98 (2007).

68.                    Chartrel, N., Alvear-Perez, R., Leprince, J., Iturrioz, X., Réaux-Legoazigo, A., Audinot, V., Chomarat, P., Cogé, F., Nosjean, O., Rodriguez, M., Galizzi, J.P., Boutin, J.A., Vaudry, H. and Llorens-Cortes, C.:Comment on “Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake”. Science 315:766-767 (2007).

69.                    Egido, E.M., Hernández, R., Leprince, J., Chartrel, N., Vaudry, H., Marco, J. and Silvestre, R.A.: 26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas. Peptides 28:725-730 (2007).

70.                    Falluel-Morel, A., Chafai, M., Vaudry, D., Basille, M., Cazillis, M., Aubert, N., Louiset, E., de Jouffrey, S., Le Bigot, J.F., Fournier, A., Gressens, P., Rostène, W., Vaudry, H. and Gonzalez, B.J.: The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells. J. Neuroendocrinol. 19:321-327 (2007).

71.                    Gouardères, C., Mazarguil, H., Mollereau, C., Chartrel, N., Leprince, J., Vaudry, H. and Zajac, J.M.: Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgS binding. Neuropharmacology 52:376-386 (2007).

72.                    Gourcerol, G., Gallas, S., Mounien, L., Leblanc, I., Bizet, P., Boutelet, I., Leroi, A.M., Ducrotté, P., Vaudry, H. and Jégou, S.: Gastric electrical stimulation modulates hypothalamic corticotropin-releasing factor-producing neurons during post- operative ileus in rat. Neuroscience 148:775-781 (2007).

73.                    Thoüennon, E., Elkahloun, A.G., Guillemot, J., Gimenez-Roqueplo, A.P., Bertherat, J., Pierre, A., Ghzili, H., Grumolato, L., Muresan, M., Klein, M., Lefebvre, H., Ouafik, L., Vaudry, H., Plouin, P.F., Yon, L. and Anouar, Y.: Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy. J. Clin. Endocrinol. Metab. 92:4865-4872 (2007).

74.                    Titon, I., Cailleux-Bounacer, A., Basuyau, J.P., Lefebvre, H., Savouré, A. andKuhn, J.M.: Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism. Eur. J. Endocrinol. 157:351-357 (2007).

75.                    Vezzosi, D., Cartier, D., Régnier, C., Otal, P., Bennet, A., Parmentier, F., Plantavid, M., Lacroix, A., Lefebvre, H. and Caron, P.: Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur. J. Endocrinol. 156:21-31 (2007).



76.                    Bruzzone, F., Lectez, B., Tollemer, H., Leprince, J., Dujardin, C., Rachidi, W., Chatenet, D., Baroncini, M., Beauvillain, J.C., Vallarino, M., Vaudry, H. and Chartrel, N. : Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cord. J. Neurochem. 99:616-627 (2006).

77.                    Caron, P., Cogne, M., Raingeard, I., Bex-Bachellerie, V., and Kuhn, J.M.: Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly. Clin. Endocrinol. 64:209-214. (2006).

78.                    Chartrel, N., Bruzzone, F., Leprince, J., Tollemer, H., Anouar, Y., Do-Régo, J.C., Ségalas-Milazzo, I., Guilhaudis, L., Cosette, P., Jouenne, T., Simonnet, G., Vallarino, M., Beauvillain, J.C., Costentin, J. and Vaudry, H.: Structure and functions of the novel hypothalamic RFamide neuropeptides R-RFa and 26RFa in vertebrates. Peptides 27:1110-1120 (2006).

79.                    Do-Rego, J.L., Acharjee, S., Seong, J.Y., Galas, L., Alexandre, D., Bizet, P., Burlet, A., Kwon, H.B., Luu-The, V., Pelletier, G. and Vaudry, H.: Vasotocin and mesotocin stimulate the biosynthesis of neurosteroids in the frog brain. J. Neurosci. 26:6749-6760 (2006).

80.                    Do-Rego, J.C., Leprince, J., Chartrel, N., Vaudry, H. and Costentin, J.: Behavioral effects of 26RFa and related peptides. Peptides 27:2715-2721 (2006).

81.                    Groussin, L., Horvath, A., Jullian, E., Boikos, S., Rene-Corail, F., Lefebvre, H., Cephise-Velayoudom, F.L., Vantyghem, M.C., Chanson, P., Conte-Devolx, B., Lucas, M., Gentil, A., Malchoff,C.D., Bertagna, X., Stratakis, C.A., Bertherat, J.: A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J. Clin. Endocrinol. Metab. 91:1943-1949 (2006).

82.                    Guillemot, J., Anouar, Y., Montero-Hadjadje, M., Grouzmann, E., Grumolato, L., Roshmaninho-Salgado, J., Turquier, V., Duparc, C., Lefebvre, H., Plouin, P.F., Klein, M., Museran, M., Chow, B.K.C., Vaudry, H. and Yon, L.: Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma. Int. J. Cancer 118:2003-2012 (2006).

83.                    Kodjo, M., Contesse, V., Do Rego, J.L., Aklikokou, K., Titrikou, S., Gbeassor, M. and Vaudry, H.: In vitro effects of crude extracts of Parkia biglobosa (Mimosaceae), Stereospermum kunthianum (Bignoniaceae) and Biophytum petersianum (Oxalidaceae) on corticosteroid secretion in rat. J. Steroid Biochem. Mol. Biol. 100:202-208 (2006).

84.                    Louiset, E., Contesse, V., Groussin, L., Cartier, D., Duparc, C., Barrande, G., Bertherat, J., Vaudry, H. and Lefebvre, H.: Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing’s syndrome. J. Clin. Endocrinol. Metab. 91:4578-4586 (2006).

85.                    Mounien, L., Bizet, P., Boutelet, I., Gourcerol, G., Fournier, A., Vaudry, H. and Jégou, S.: Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience 143:155-163 (2006).

86.                    Navarro, V.M., Fernández-Fernandez, R., Nogueiras, R., Vigo, E., Tovar, S., Chartrel, N., Le Marec, O., Leprince, J., Aguilar, E., Pinilla, L., Dieguez, C., Vaudry, H. and Tena-Sempere, M.: Novel role of 26RFa, a hypothalamic RFamide orexigenic peptide, as putative regulator of the gonadotropic axis. J. Physiol. London 573:237-249 (2006).

87.                    Perraudin, V., Delarue, C., Lefebvre, H., Do Rego, J.L., Vaudry, H. and Kuhn, J.M.: Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. J. Clin. Endocrinol. Metab. 91:1566-1572 (2006).

88.                    Sicard, F., Contesse, V., Lefebvre, H., Ait-Ali, D., Gras, M., Cartier, D., Decker, A., Chartrel, N., Anouar, Y., Vaudry, H. and Delarue, C.: The N-terminal neurotensin fragment, NT1-11, inhibits cortisol secretion by human adrenocortical cells. J. Clin. Endocrinol. Metab. 91:3131-3137 (2006).

89.                    Vallarino, M., Bruzzone, F., Mathieu, M., Chartrel, N., Vieau, D., Ciarlo, M., Fournier, A., and Vaudry, H. : Ontogeny of the somatostatin variant [Pro2,Met13]somatostatin-14 in the brain, pituitary and sensory organs of the frog Rana esculenta. J. Comp. Neurol. 497:717-733 (2006).